STOCK TITAN

Trevor Bezdek (GDRX) receives 110K RSUs vesting in 2027

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Bezdek Trevor reported acquisition or exercise transactions in this Form 4 filing.

GoodRx Holdings, Inc. director Trevor Bezdek reported an equity award and updated holdings in Class A common stock. He received 110,294 restricted stock units, each representing one share, at a price of $0.00 per unit. These restricted stock units vest 100% on December 31, 2027, subject to his continued service.

Following this grant, Bezdek holds 270,376 shares of Class A common stock directly. The filing also lists indirect holdings by grantor retained annuity trusts TB 2024-2 GRAT and TB 2025 GRAT, where he is sole trustee and annuitant, as well as JB 2024-2 GRAT and JB 2025 GRAT, which are managed by his spouse and in which he has no pecuniary interest and disclaims beneficial ownership.

Positive

  • None.

Negative

  • None.
Insider Bezdek Trevor
Role null
Type Security Shares Price Value
Grant/Award Class A Common Stock 110,294 $0.00 --
holding Class A Common Stock -- -- --
holding Class A Common Stock -- -- --
holding Class A Common Stock -- -- --
holding Class A Common Stock -- -- --
holding Class A Common Stock -- -- --
Holdings After Transaction: Class A Common Stock — 270,376 shares (Direct, null); Class A Common Stock — 543,377 shares (Indirect, By TB 2024-2 GRAT)
Footnotes (1)
  1. Reflects restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Class A common stock. The restricted stock units will vest 100% on December 31, 2027, subject to continued service through the applicable vesting date. Share held directly by TB 2024 -2 GRAT, a grantor retained annuity trust (the "TB 2024-2 GRAT"). The Reporting Person serves as the sole trustee and sole annuitant of the TB 2024-2 GRAT. Share held directly by TB 2025 GRAT, a grantor retained annuity trust (the "TB 2025 GRAT"). The Reporting Person serves as the sole trustee and sole annuitant of the TB 2025 GRAT. Share held directly by JB 2024-2 GRAT, a grantor retained annuity trust (the "JB 2024-2 GRAT"). Jana Bezdek, the Reporting Person's spouse, serves as the sole trustee and sole annuitant of the TB 2024-2 GRAT. The Reporting Person has no pecuniary interest in or voting or investment control over the shares of Class A Common Stock held by the TB 2024-2 GRAT and disclaims beneficial ownership of such shares. This filing is not an admission or acknowledgment that the Reporting Person is the beneficial owner of such shares. Share held directly by JB 2025 GRAT, a grantor retained annuity trust (the " JB 2025 GRAT"). Jana Bezdek, the Reporting Person's spouse, serves as the sole trustee and sole annuitant of the JB 2025 GRAT. The Reporting Person has no pecuniary interest in or voting or investment control over the shares of Class A Common Stock held by the JB 2025 GRAT and disclaims beneficial ownership of such shares. This filing is not an admission or acknowledgment that the Reporting Person is the beneficial owner of such shares.
RSU grant size 110,294 units Restricted stock units, each for one Class A share
RSU grant price $0.00 per unit Grant, award, or other acquisition
RSU vesting date December 31, 2027 100% vesting subject to continued service
Direct shares after grant 270,376 shares Class A common stock directly held after transaction
TB 2025 GRAT holdings 2,089,343 shares Class A common stock held indirectly by TB 2025 GRAT
TB 2024-2 GRAT holdings 543,377 shares Class A common stock held indirectly by TB 2024-2 GRAT
restricted stock units financial
"Reflects restricted stock units. Each restricted stock unit represents a contingent right to receive one share"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
grantor retained annuity trust financial
"a grantor retained annuity trust (the "TB 2024-2 GRAT")"
A grantor retained annuity trust (GRAT) is an estate-planning tool where the person who creates the trust transfers assets into it but receives fixed cash payments (an annuity) from the trust for a set number of years; whatever remains after that term passes to designated beneficiaries. It matters to investors because it can shift future appreciation of assets out of the creator’s taxable estate—like putting an asset into a timed vending machine that pays you fixed amounts while any extra value that grows inside the machine goes to heirs with reduced gift or estate tax consequences.
pecuniary interest financial
"The Reporting Person has no pecuniary interest in or voting or investment control over the shares"
beneficial ownership financial
"disclaims beneficial ownership of such shares. This filing is not an admission or acknowledgment"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Bezdek Trevor

(Last)(First)(Middle)
C/O GOODRX HOLDINGS, INC.
2701 OLYMPIC BOULEVARD

(Street)
SANTA MONICA CALIFORNIA 90404

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
GoodRx Holdings, Inc. [ GDRX ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/08/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Class A Common Stock06/08/2026A110,294(1)A$0270,376D
Class A Common Stock543,377IBy TB 2024-2 GRAT(2)
Class A Common Stock2,089,343IBy TB 2025 GRAT(3)
Class A Common Stock1IBy Spouse
Class A Common Stock543,377IBy JB 2024-2 GRAT(4)
Class A Common Stock2,089,343IBy JB 2025 GRAT(5)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Reflects restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Class A common stock. The restricted stock units will vest 100% on December 31, 2027, subject to continued service through the applicable vesting date.
2. Share held directly by TB 2024 -2 GRAT, a grantor retained annuity trust (the "TB 2024-2 GRAT"). The Reporting Person serves as the sole trustee and sole annuitant of the TB 2024-2 GRAT.
3. Share held directly by TB 2025 GRAT, a grantor retained annuity trust (the "TB 2025 GRAT"). The Reporting Person serves as the sole trustee and sole annuitant of the TB 2025 GRAT.
4. Share held directly by JB 2024-2 GRAT, a grantor retained annuity trust (the "JB 2024-2 GRAT"). Jana Bezdek, the Reporting Person's spouse, serves as the sole trustee and sole annuitant of the TB 2024-2 GRAT. The Reporting Person has no pecuniary interest in or voting or investment control over the shares of Class A Common Stock held by the TB 2024-2 GRAT and disclaims beneficial ownership of such shares. This filing is not an admission or acknowledgment that the Reporting Person is the beneficial owner of such shares.
5. Share held directly by JB 2025 GRAT, a grantor retained annuity trust (the " JB 2025 GRAT"). Jana Bezdek, the Reporting Person's spouse, serves as the sole trustee and sole annuitant of the JB 2025 GRAT. The Reporting Person has no pecuniary interest in or voting or investment control over the shares of Class A Common Stock held by the JB 2025 GRAT and disclaims beneficial ownership of such shares. This filing is not an admission or acknowledgment that the Reporting Person is the beneficial owner of such shares.
Remarks:
/s/ Gracye Cheng, Attorney-in-Fact for Trevor Bezdek06/10/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did Trevor Bezdek report in this GoodRx (GDRX) Form 4 filing?

Trevor Bezdek reported an equity award and updated his GoodRx holdings. He received 110,294 restricted stock units and now directly holds 270,376 shares of Class A common stock after the grant.

How many restricted stock units did Trevor Bezdek receive from GoodRx (GDRX)?

Trevor Bezdek received 110,294 restricted stock units from GoodRx. Each unit represents a contingent right to one share of Class A common stock, granted at a price of $0.00 per share as compensation.

When do Trevor Bezdek’s GoodRx (GDRX) restricted stock units vest?

The restricted stock units vest 100% on December 31, 2027. Vesting is contingent on Trevor Bezdek’s continued service with GoodRx through that vesting date, according to the filing’s footnote disclosure.

What are Trevor Bezdek’s direct GoodRx (GDRX) share holdings after this Form 4?

After the reported grant, Trevor Bezdek directly holds 270,376 shares of GoodRx Class A common stock. This figure reflects his direct ownership position following the 110,294 restricted stock unit award.

How are GoodRx (GDRX) shares held through GRATs attributed in this filing?

Some shares are held by TB 2024-2 GRAT and TB 2025 GRAT, where Trevor Bezdek is sole trustee and annuitant. Other shares are held by JB 2024-2 GRAT and JB 2025 GRAT, managed by his spouse, where he disclaims beneficial ownership.

Does Trevor Bezdek have pecuniary interest in all reported GoodRx (GDRX) indirect holdings?

No. For shares held by JB 2024-2 GRAT and JB 2025 GRAT, the filing states he has no pecuniary interest or voting or investment control and expressly disclaims beneficial ownership of those GoodRx Class A shares.